Romano Brothers & Co’s Verastem VSTM Stock Holding History

Romano Brothers & Co’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-83	Closed	-$403	–	971
2022 Q4	$403	Buy	+83	New	+$407	﹤0.01%	1025

Other funds holding VSTM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Romano Brothers & Co's VSTM Position: Q1 2023 in Review

Romano Brothers & Co sold out of Verastem (VSTM) in Q1 2023, closing a stake of 83 shares — an estimated $403 sold.

Romano Brothers & Co first reported a position in VSTM in Q4 2022 and held it in 1 quarter. The position peaked at $403 in Q4 2022. 80 funds tracked by Wall St. Rank hold VSTM as of Q1 2023.

Romano Brothers & Co reported no remaining Verastem position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 83 Verastem shares in Q1 2023, an estimated $403.
Romano Brothers & Co first reported a position in Verastem in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Verastem position peaked at $403 in Q4 2022.
80 funds tracked by Wall St. Rank held Verastem as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.